Orchid Pharma purchases Kancheepuram land, ends DBS lease
- Orchid Pharma purchased land at Patibulum Village, Kancheepuram
- Lease arrangement with DBS Bank India Limited is now concluded
- Company secured permanent ownership and clarity on property rights
- Disclosure made under SEBI Listing Regulations, 2015
*this image is generated using AI for illustrative purposes only.
Orchid Pharma has purchased land situated at Patibulum Village, Kancheepuram District, Tamil Nadu. This acquisition concludes the company's lease arrangement with DBS Bank India Limited and secures permanent ownership of the property.
The transaction marks the cessation of DBS Bank's rights and interest in the said property. The move provides certainty and clarity regarding the company's ownership status of the asset.
Regulatory Disclosure
The company filed an intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The disclosure references an earlier intimation dated June 6, 2025, which concerned the disposal of a dispute related to the lease rental of the subject property.
Transaction Details
The purchase resolves the prior lease structure entirely. Key aspects of the development include:
- Location: Patibulum Village, Kancheepuram District, Tamil Nadu
- Counterparty: DBS Bank India Limited
- Outcome: Permanent closure of the lease arrangement
- Status: Full ownership rights vested in Orchid Pharma
Historical Stock Returns for Orchid Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.35% | +10.38% | +10.49% | +107.91% | +40.43% | +167.41% |
How will the transition from a lease to owned asset structure impact Orchid Pharma's balance sheet leverage and depreciation schedules in upcoming quarterly reports?
What are the potential tax implications or capital gains considerations arising from the final settlement of the dispute with DBS Bank India Limited?
Does the permanent ownership of the Kancheepuram facility enable Orchid Pharma to expand manufacturing capacity or attract new long-term contract clients?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
